Highlights

    April 2016 in “ JAMA Dermatology
    Image of study
    TLDR Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.
    In the April 2016 issue of JAMA Dermatology, several studies were highlighted. Schmidt et al conducted a retrospective cross-sectional study and found that while acne is common in women with polycystic ovary syndrome (PCOS), it is not a distinguishing feature for diagnosis; instead, hirsutism and acanthosis nigricans were more useful indicators. Nagpal et al's cross-sectional study revealed that postadolescent men with acne are more likely to have insulin resistance, which could be a precursor to prediabetes and type 2 diabetes, suggesting the need for long-term monitoring. Geller et al's survey indicated that most melanoma patients had few nevi and no atypical nevi (AN), with younger patients having thick melanomas associated with fewer total nevi but more AN, challenging the reliance on total nevus count for melanoma risk assessment. Thompson et al's meta-analysis showed that tumor depth and diameter exceeding 20 mm are significant risk factors for local recurrence, metastasis, and disease-specific death in cutaneous squamous cell carcinoma (CSCC). Lastly, Egeberg et al's population-based cohort study found that hidradenitis suppurativa (HS) is associated with an increased risk of cardiovascular events and all-cause mortality, independent of confounders.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 563 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    6 / 1000+ results